| BSE: 500257 | Sector: Health care |
| NSE: LUPIN | ISIN Code: INE326A01037 |
| BSE 00:00 | 23 Jan | 864.25 |
1.05 (0.12%) |
OPEN
864.00 |
HIGH
873.10 |
LOW
860.00 |
| NSE 00:00 | 23 Jan | 864.60 |
-0.85 (-0.10%) |
OPEN
866.00 |
HIGH
873.60 |
LOW
859.25 |
| OPEN | 864.00 |
| PREVIOUS CLOSE | 863.20 |
| VOLUME | 33728 |
| 52-Week high | 986.00 |
| 52-Week low | 723.55 |
| P/E | 26.86 |
| Mkt Cap.(Rs cr) | 39,099 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular Diabetology Asthma Pediatric CNS GI Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment....> More
| Parameter | Values | ||
| Market Cap | ( cr) |
39,099 | |
| EPS - TTM | () |
[*S] | 32.18 |
| P/E Ratio | (X) | [*S] | 26.86 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 250.00 | |
| Latest Dividend Date | 30 Jul 2018 | ||
| Dividend Yield | (%) | 0.58 | |
| Book Value / Share | () |
[*S] | 360.90 |
| P/B Ratio | () |
[*S] | 2.39 |
Lupin recalls over 23,000 bottles of antibiotic drug for being sub-potent
Lupin, JMC Projects and Fortis Healthcare among top stocks to track
Lupin plans expansion, eyes Europe growth via acquisitions and launches
Three Nifty Pharma stocks that can rise up to 10% from the current levels
Lupin ties up with US-based AbbVie for cancer drug, to earn $ 1 billion
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Board Meeting Intimation for To Consider And Take On Record Unaudited Financial Results For The Quar
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 3951.06 | 3951.96 | -0.02 |
| Other Income | 231.03 | 77.98 | 196.27 |
| Total Income | 4182.09 | 4029.94 | 3.78 |
| Total Expenses | 3401.42 | 3098.91 | 9.76 |
| Operating Profit | 780.67 | 931.03 | -16.15 |
| Net Profit | 268.45 | 456.87 | -41.24 |
| Equity Capital | 90.44 | 90.37 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Cipla | 509.60 | 0.52 | 41055.93 |
| Biocon | 670.30 | 0.30 | 40218.00 |
| Divi's Lab. | 1503.70 | 0.09 | 39915.72 |
| Lupin | 864.25 | 0.12 | 39098.67 |
| Cadila Health. | 342.25 | -0.87 | 35036.13 |
| Torrent Pharma. | 1909.00 | -0.24 | 32304.10 |
| Glaxosmi. Pharma | 1410.10 | -0.47 | 23888.50 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 0.20% | 0.16% | -0.59% | -0.54% |
| 1 Month | 0.80% | 0.72% | 1.03% | 0.72% |
| 3 Month | 1.52% | 1.60% | 6.68% | 6.75% |
| 6 Month | 8.06% | 8.06% | -1.66% | -2.28% |
| 1 Year | -7.67% | -7.76% | -0.09% | -2.28% |
| 3 Year | -49.66% | -49.77% | 47.77% | 45.93% |
| Today's Low/High | 860.00 |
|
873.10 |
| Week Low/High | 845.50 |
|
879.00 |
| Month Low/High | 815.00 |
|
879.00 |
| YEAR Low/High | 723.55 |
|
986.00 |
| All TIME Low/High | 0.80 |
|
2127.00 |
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
Details